REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr. Liptakne es Tarsa Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Dr. LIPTAKNE es Tarsa Gyogyszerkiskereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Dr. Liptakne es Tarsa Bt. is an enterprise located in Hungary, with the main office in Mezotur. The company operates in the Pharmacies and Drug Stores industry. The company was established on July 24, 1995. 8 (2024) employees currently work for Dr. Liptakne es Tarsa Bt.. In 2023, the company reported a net sales revenue increase of 7.09%. Its’ total assets recorded a growth of 18.69%. Dr. Liptakne es Tarsa Bt.’s net profit margin increased by 7.17% in 2023.

Headquarters
Koztarsasag u. 1.
Mezotur; Jasz-Nagykun-Szolnok; Postal Code: 5400

Contact Details: Purchase the Dr. Liptakne es Tarsa Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Liptakne es Tarsa Bt. report to view the information.
Outstanding Shares:
Purchase the Dr. Liptakne es Tarsa Bt. report to view the information.
Registered Capital:
Purchase the Dr. Liptakne es Tarsa Bt. report to view the information.
Financial Auditors:
Purchase the Dr. Liptakne es Tarsa Bt. report to view the information.
Incorporation Date:
July 24, 1995
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Dr. Liptakne es Tarsa Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.09%▲
Total operating revenue
6.65%▲
Operating profit (EBIT)
832.79%▲
EBITDA
255.84%▲
Net Profit (Loss) for the Period
1863.01%▲
Total assets
18.69%▲
Total equity
26.1%▲
Operating Profit Margin (ROS)
7.29%▲
Net Profit Margin
7.17%▲
Return on Equity (ROE)
19.37%▲
Quick Ratio
0.41%▲
Cash Ratio
0.71%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo